2003
DOI: 10.1148/radiol.2261011893
|View full text |Cite
|
Sign up to set email alerts
|

Living Renal Donors: Optimizing the Imaging Strategy—Decision- and Cost-effectiveness Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
15
0

Year Published

2005
2005
2022
2022

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(15 citation statements)
references
References 55 publications
0
15
0
Order By: Relevance
“…Increased donor willingness to undergo evaluation and donation benefits recipients. Transplant centers benefit by reduced donor evaluation costs (28). As for surgeons, successful donor and recipient procedures can be accomplished despite consternation with unanticipated findings due to inaccurate scans.…”
Section: Discussionmentioning
confidence: 99%
“…Increased donor willingness to undergo evaluation and donation benefits recipients. Transplant centers benefit by reduced donor evaluation costs (28). As for surgeons, successful donor and recipient procedures can be accomplished despite consternation with unanticipated findings due to inaccurate scans.…”
Section: Discussionmentioning
confidence: 99%
“…Specific situations in which spillover effects are critical inputs for decision analysis have been identified, including for measurement reasons, such as utilities for health states of very young children in which the parent proxy cannot reasonably separate their own utility from that of the child 24 , or for face validity reasons, such as living organ transplant in which both donor and recipient are integral to the decision. 25 The study reported here estimated the spillover disutility of all chronic conditions experienced by a sample of the US population, measured using one utility instrument(the EuroQol-5D (EQ-5D)). These values will inform economic evaluations based on QALYs.…”
Section: Introductionmentioning
confidence: 99%
“…Clinical research over many years including calculation of the ICUR of different diseases and comparative therapy and cost-effectiveness analyses of therapy related to chronic renal failure [5,6,7,8,9,10,11] have suggested that prevention of renal failure in patients with diabetes costs approximately USD 2,000-30,000/Qaly, which is better than the cost of normal HD (dialysis in regular facilities) of about USD 50,000/Qaly. These studies also showed that renal transplantation (including donors from fatalities and patients aged ≥65 years) cost USD 10,000-70,000/Qaly, generally indicating good value.…”
Section: Discussionmentioning
confidence: 99%